Therapy Market Research Reports & Industry Analysis

Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.

Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.

The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.

Found 2149 publications
Global Allergy Immunotherapy Market (2017-2021 Edition) US$ 800.00

... titled “Global Allergy Immunotherapy Market (2017-2021 Edition)”, provides an in-depth analysis of the global allergy immunotherapy market by value, by methods of administration, by region, etc. The report provides a regional analysis of the allergy immunotherapy market, including ...

Oct, 2017 70 pages
Global Testosterone Replacement Therapy Market Report 2017 US$ 2,350.00

... relatively optimistic growth, the past four years, Testosterone Replacement Therapy market size to maintain the average annual growth rate ... years, Testosterone Replacement Therapy market size will be further expanded, we expect that by 2021 , The market size of the Testosterone Replacement Therapy will reach ...

Oct, 2017 130 pages
Radiation Injury - Pipeline Review, H2 2017 US$ 2,000.00

... releases. The Radiation Injury (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Radiation Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

Oct, 2017 46 pages
Heavy Metal Poisoning - Pipeline Review, H2 2017 US$ 2,000.00

... releases. The Heavy Metal Poisoning (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Heavy Metal Poisoning and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

Oct, 2017 40 pages
Cystic Fibrosis Therapeutics Market (By Major Marketed Products, Pharmacological Class, & Geography) and Pipeline Analysis – Global Forecast to 2024 US$ 1,400.00

... Fibrosis Therapeutics Market & Forecast (2014 – 2024) 2. Global Cystic Fibrosis Therapeutics Market - Major Marketed Products Sales & Forecast (2012 - 2024) 3. Global Cystic Fibrosis Therapeutics Market - Pharmacological Class Sales & Forecast (2015 – 2021) 4. By Geography - Cystic Fibrosis Therapeutics ...

Oct, 2017 121 pages
ForeSights: Salt Therapy - An old-fashioned, non-invasive treatment enjoying a renaissance as a new health and wellness solution US$ 495.00

... of relaxation, pain relief, and stress relief - even inducing a meditative state in some cases. Dry salt therapy is believed to provide relief from respiratory ailments including asthma, sinusitis, bronchitis, and COPD. It may also ...

Sep, 2017 23 pages
Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Pipeline Review, H2 2017 US$ 3,500.00

... Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

Sep, 2017 69 pages
Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) - Pipeline Review, H2 2017 US$ 3,500.00

... identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) development landscape Develop ...

Sep, 2017 63 pages
Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Pipeline Review, H2 2017 US$ 3,500.00

... Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

Sep, 2017 63 pages
Pseudomonas aeruginosa Pneumonia - Pipeline Review, H2 2017 US$ 2,000.00

... . The Pseudomonas aeruginosa Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pseudomonas aeruginosa Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

Sep, 2017 32 pages
Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H2 2017 US$ 2,000.00

... . The Marburgvirus Infections (Marburg Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Marburgvirus Infections (Marburg Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

Sep, 2017 78 pages
Malignant Pleural Effusion - Pipeline Review, H2 2017 US$ 2,000.00

... releases. The Malignant Pleural Effusion (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Malignant Pleural Effusion and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

Sep, 2017 32 pages
Influenzavirus B Infections - Pipeline Review, H2 2017 US$ 2,000.00

... . The Influenzavirus B Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenzavirus B Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

Sep, 2017 120 pages
Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2017 US$ 2,000.00

... . The Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H5N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

Sep, 2017 151 pages
Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2017 US$ 2,000.00

... . The Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H1N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

Sep, 2017 209 pages
Hepatic - Colorectal Metastasis - Pipeline Review, H2 2017 US$ 2,000.00

... releases. The Hepatic - Colorectal Metastasis (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hepatic - Colorectal Metastasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

Sep, 2017 39 pages
Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H2 2017 US$ 2,000.00

... . The Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Epstein-Barr Virus (HHV-4) Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

Sep, 2017 74 pages
Ependymoma - Pipeline Review, H2 2017 US$ 2,000.00

... releases. The Ependymoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ependymoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

Sep, 2017 131 pages
Dupuytren Contracture - Pipeline Review, H2 2017 US$ 2,000.00

... releases. The Dupuytren Contracture (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Dupuytren Contracture and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

Sep, 2017 31 pages
Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2017 US$ 2,000.00

... . The Influenza A Virus, H3N2 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H3N2 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

Aug, 2017 127 pages
Global Pediatric Proton Therapy Market & Forecast (10 Countries Market Data), Patients Treated US$ 2,200.00

... therapy centers as well as its elongated history of proton therapy. USA leads the Pediatric Proton Therapy Market globally USA has the highest pediatric proton therapy market ... and Japan. This report provides the data on USA Pediatric Proton Therapy Market & Patients numbers, in 36 Cancer Types. Out of these ...

Aug, 2017
Global Pruritus Therapeutic Market 2017-2021 US$ 3,500.00 US$ 2,500.00

... on geography: Americas APAC EMEA Technavio's report, Global Pruritus Therapeutic Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The ...

Aug, 2017 81 pages
Global Radiotherapy Market Analysis & Forecast Report 2017 US$ 2,800.00

The Global Radiotherapy Market Analysis & Forecast Report 2017 is a professional and in-depth study on the current state of the Radiotherapy Market. The report analysis the global market of Radiotherapy by main manufactures and geographic ...

Jul, 2017 95 pages
Global Continuous Renal Replacement Therapy (CRRT) Market Analysis & Forecast Report 2017 US$ 2,800.00

The Global Continuous Renal Replacement Therapy (CRRT) Market Analysis & Forecast Report 2017 is a professional and in-depth study on the current state of the Continuous Renal Replacement Therapy (CRRT) Market. The report ...

Jul, 2017 95 pages
2017 US Physical Therapy Tape Industry Report US$ 2,600.00 Aug, 2017 105 pages
2017 Japan Physical Therapy Tape Industry Report US$ 2,600.00 Aug, 2017 113 pages
2017 India Physical Therapy Tape Industry Report US$ 2,600.00 Aug, 2017 109 pages
2017 Europe Physical Therapy Tape Industry Report US$ 2,600.00 Aug, 2017 120 pages
2017 China Physical Therapy Tape Industry Report US$ 2,600.00 Aug, 2017 108 pages
Complex Regional Pain Syndrome - Pipeline Review, H2 2017 US$ 2,000.00

... . The Complex Regional Pain Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Complex Regional Pain Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development ...

Jul, 2017 39 pages
Cluster Headache Syndrome - Pipeline Review, H2 2017 US$ 2,000.00

... . The Cluster Headache Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cluster Headache Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development ...

Jul, 2017 39 pages
Global Proton Therapy Market (28 Countries Analysis), Patients Treated, List of Proton Therapy Centers, Start of Treatment, Specifications & Company Analysis US$ 1,950.00

... Points 1. Global Proton Therapy Actual & Potential Market Analysis (2010 - 2022) 2. Global Proton Therapy Actual & Potential Candidate Analysis (2010 - 2022) 3. Global Proton Therapy Market Share Analysis (2010 - 2022) 4. Global Proton Therapy Candidate Share Analysis (2010 - 2022) 5. Proton Therapy Actual & Potential Market - Regional ...

Jul, 2017 411 pages
Radiotherapy Market by Type (External Beam Radiation Therapy, Internal Radiation Therapy/Brachytherapy, and Systemic Radiation Therapy), and End User (Hospitals & Clinics and Ambulatory... US$ 5,370.00 US$ 4,296.00

... for radiotherapy. Key Players are profiled and their strategies are analyzed thoroughly to understand competitive outlook of the global market. KEY MARKET SEGMENTS BY TYPE External Beam Radiation Therapy By Product Compact Advanced Radiotherapy Systems Cyberknife Gamma Knife Tomotherapy Proton Therapy Systems Conventional Radiotherapy ...

Jun, 2017 140 pages
Intravenous (IV) Therapy and Vein Access Market by Product Type (Implantable Port [Single Lumen Implantable Port and Double Lumen Implantable Port], Intravenous Catheter [Peripheral... US$ 5,370.00 US$ 4,296.00

Intravenous (IV) therapy is the process of infusion of liquid substances, such as electrolytes, medicines, nutrition, and blood-based products, directly into the vein as a therapeutic treatment. Intravenous therapy ... STKEHOLDERS The study provides an in-depth analysis of the global intravenous therapy and vein access market, with current trends and future estimations to elucidate ...

Jun, 2017 175 pages
Global Cystic Fibrosis Therapeutics Market Outlook 2022 US$ 3,000.00

... by RNCOS titled, "Global Cystic Fibrosis Therapeutics Market Outlook 2022”, unfolds the market dynamics of the cystic fibrosis therapeutics market. According to this new research report, the market for cystic fibrosis therapeutics was valued at US$ 1.94 Billion ... for largest share in the total cystic fibrosis therapeutics market in 2016. Additionally, the report covers the geographic analysis of the global cystic fibrosis therapeutics market by segmenting into three major ...

Jul, 2017 140 pages
Physical & Occupational Therapists Revenues Global Report US$ 950.00

... Coupon value of $300. PHYSICAL & OCCUPATIONAL THERAPISTS REVENUES WORLD REPORT DATABASE EDITION The Market for Physical & Occupational Therapists Revenues in each country by Products & Services. The Physical & Occupational Therapists Revenues World Report covers ...

Jul, 2017 839 pages
Physical & Occupational Therapists Purchasing World Report US$ 950.00

PHYSICAL & OCCUPATIONAL THERAPISTS PURCHASING WORLD PDF REPORT See descriptive brochure: here The Physical & Occupational Therapists Purchasing World Report gives data on a list of 42 categories of Raw Materials, Semi- ... , by each country, by Year. This Physical & Occupational Therapists Purchasing World Report is a PDF Summary Edition.807 pages. Updated monthly. UPGRADE: A Purchasing World Database Edition of this ...

Jul, 2017 807 pages
Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse US$ 4,995.00

Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse SUMMARY The pain therapeutics market ...

Jun, 2017 147 pages
Global Stem Cell Therapy Market: Size, Trend, Share, Opportunity Analysis & Forecast, 2014–2025 US$ 3,619.00

... , global stem cell therapy market is expected to grow at a CAGR of 12.2% from 2017 to 2025. According to therapy mode, the market is divided into autologous stem cell therapy and allogeneic stem cell therapy. According to application, the market is divided ... of stem cell therapy. Restraints: Lack of infrastructure needed for the R&D of stem cell therapy. Ethical issues associated with the embryonic stem cells. MARKET PLAYERS: The top players in the global stem cell therapy market include ...

Mar, 2017
Global Plasma Therapy Market: Size, Trend, Share, Opportunity Analysis & Forecast, 2014–2025 US$ 3,619.00

... to sports medicine and orthopedic treatments. Global plasma therapy market is expected to grow at a CAGR of 13.5% from 2017 to 2025. Based on type, the global plasma therapy market is segmented as Leucocyte-rich PRP ... of platelet rich plasma for treatment of various diseases. Restraints: High cost of plasma therapy. MARKET PLAYERS: The top players in the global plasma therapy market include Biolife Plasma Services, Biotest ...

Mar, 2017
Usher Syndrome - Pipeline Review, H1 2017 US$ 2,000.00

... pipeline guide Usher Syndrome - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Usher Syndrome (Genetic Disorders), complete with analysis by stage of development ...

Jun, 2017 34 pages
Influenza A Virus, H7N9 Subtype Infections - Pipeline Review, H1 2017 US$ 2,000.00

... pipeline guide Influenza A Virus, H7N9 Subtype Infections - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Influenza A Virus, H7N9 Subtype Infections (Infectious Disease), complete with analysis by stage of development ...

Jun, 2017 73 pages
Hyperinsulinemia - Pipeline Review, H1 2017 US$ 2,000.00

... pipeline guide Hyperinsulinemia - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Hyperinsulinemia (Metabolic Disorders), complete with analysis by stage of development ...

Jun, 2017 43 pages
Graves Diseases - Pipeline Review, H1 2017 US$ 2,000.00

... pipeline guide Graves Diseases - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Graves Diseases (Hormonal Disorders), complete with analysis by stage of development ...

Jun, 2017 30 pages
Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) - Pipeline Review, H1 2017 US$ 3,500.00

... Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) The report reviews Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) targeted therapeutics under development ...

Jun, 2017 60 pages
Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) - Pipeline Review, H1 2017 US$ 3,500.00

... therapeutic landscape for Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) The report reviews Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) targeted therapeutics under development ...

Jun, 2017 44 pages
Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Pipeline Review, H1 2017 US$ 3,500.00

... therapeutic landscape for Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) The report reviews Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) targeted therapeutics under development ...

Jun, 2017 54 pages
Dystrophin (DMD) - Pipeline Review, H1 2017 US$ 3,500.00

Dystrophin (DMD) - Pipeline Review, H1 2017 SUMMARY According to the recently published report 'Dystrophin (DMD) - Pipeline Review, H1 2017'; Dystrophin (DMD) pipeline Target constitutes close to 26 molecules. Out of which approximately 23 molecules are developed ...

Jun, 2017 70 pages
2017 Global and Regional Therapeutic Stent Market Research Report Forecasts 2022 US$ 2,800.00

This report focus on Global and regional market, providing information on major players like manufacturers, suppliers, distributors, ... etc., major types, major applications from Global and major regions such as Europe, North American, South American, Asia (Excluding China ...

Jun, 2017 170 pages
2017 Global and Regional Therapeutic Nuclear Medicines Market Research Report Forecasts 2022 US$ 2,800.00

This report focus on Global and regional market, providing information on major players like manufacturers, suppliers, distributors, ... etc., major types, major applications from Global and major regions such as Europe, North American, South American, Asia (Excluding China ...

Jul, 2017 150 pages
1 2 3 4 5 >
Skip to top